Delayed
OTC Markets
11:12:28 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
0.0001
USD
|
-50.00%
|
|
-50.00%
|
0.00%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Capitalization
1 |
7.795
|
6.669
|
0.1882
|
Enterprise Value (EV)
1 |
7.792
|
6.233
|
0.937
|
P/E ratio
|
-8.32
x
|
-2.42
x
|
-0.15
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
135,326,922
x
|
63,843,296
x
|
2,279,205
x
|
EV / Revenue
|
135,276,804
x
|
59,667,541
x
|
11,349,273
x
|
EV / EBITDA
|
-
|
-4,646,211
x
|
-781,239
x
|
EV / FCF
|
-11,771,623
x
|
-22,687,488
x
|
-110,044,627
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
286
x
|
10.1
x
|
-0.36
x
|
Nbr of stocks (in thousands)
|
163,425
|
296,397
|
250,905
|
Reference price
2 |
0.0477
|
0.0225
|
0.000750
|
Announcement Date
|
4/15/21
|
4/15/22
|
3/21/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.0178
|
0.0576
|
0.1045
|
0.0826
|
EBITDA
|
-
|
-0.1464
|
-
|
-1.341
|
-1.199
|
EBIT
1 |
-0.000138
|
-0.1497
|
-0.655
|
-1.451
|
-1.288
|
Operating Margin
|
-
|
-842.23%
|
-1,137.1%
|
-1,389.2%
|
-1,560.42%
|
Earnings before Tax (EBT)
1 |
-0.000138
|
-0.1494
|
-0.6902
|
-1.811
|
-1.659
|
Net income
1 |
-0.000138
|
-0.1494
|
-0.6902
|
-1.811
|
-1.659
|
Net margin
|
-
|
-840.54%
|
-1,198.11%
|
-1,734%
|
-2,009.09%
|
EPS
|
-
|
-0.002950
|
-0.005734
|
-0.009316
|
-0.005015
|
Free Cash Flow
|
-
|
-
|
-0.662
|
-0.2747
|
-0.008515
|
FCF margin
|
-
|
-
|
-1,149.18%
|
-263%
|
-10.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/21/19
|
7/13/20
|
4/15/21
|
4/15/22
|
3/21/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
0.75
|
Net Cash position
1 |
0.04
|
0.11
|
0
|
0.44
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.6243
x
|
Free Cash Flow
|
-
|
-
|
-0.66
|
-0.27
|
-0.01
|
ROE (net income / shareholders' equity)
|
-
|
-196%
|
124%
|
-519%
|
-16,555%
|
ROA (Net income/ Total Assets)
|
-
|
-119%
|
-644%
|
-201%
|
-162%
|
Assets
1 |
-
|
0.1253
|
0.1072
|
0.8991
|
1.023
|
Book Value Per Share
2 |
0
|
0
|
0
|
0
|
-0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
-
|
Capex
|
-
|
-
|
-
|
0.01
|
-
|
Capex / Sales
|
-
|
-
|
-
|
5.46%
|
-
|
Announcement Date
|
3/21/19
|
7/13/20
|
4/15/21
|
4/15/22
|
3/21/23
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 682K | | +28.10% | 5.68B | | -33.42% | 3.61B | | -3.33% | 3.11B | | -26.20% | 2.65B | | -9.99% | 2.33B | | +40.09% | 1.89B | | +40.90% | 1.49B | | -12.94% | 1.46B | | +46.67% | 1.37B |
Alternative Medicine
|